Taconic Capital Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Taconic Capital Advisors’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-443,700	Closed	-$58.5M	–	91
2025 Q1	$58.5M	Buy	+443,700	New	+$55.3M	4.14%	6

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Taconic Capital Advisors's ITCI Position: Q2 2025 in Review

Taconic Capital Advisors sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 443,700 shares — an estimated $58.5M sold.

Taconic Capital Advisors first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $58.5M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Taconic Capital Advisors reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Taconic Capital Advisors sold 443,700 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $58.5M.
Taconic Capital Advisors first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
Taconic Capital Advisors's Intra-Cellular Therapies Inc. position peaked at $58.5M in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Taconic Capital Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.